Fresh analysis suggests that individuals who discontinue new weight-loss injections like semaglutide or tirzepatide can put back on lost weight much more quickly than those who end conventional diet and exercise regimens.
Published data in a leading medical journal points out that while obese people often shed about a fifth of their total mass while on the medication, the mass comes back at an average rate of nearly a kilo each month after stopping.
"Individuals using such drugs must be aware of the risk of quick weight regain when the medication ends," stated expert Dr. Susan Jebb.
That rate of regain means a return to starting weight within about one and a half years.
Weighing Therapies
The analysis, which looked at 37 of studies involving thousands of patients, contrasted the results of these new drugs with older methods.
Researchers emphasize that people who shed pounds through diet and exercise generally experience a more gradual creep back—around 100 grams monthly—post-intervention.
Understanding the Fast Rebound
Doctors propose the way of the injections explains the heightened rebound.
GLP-1 drugs copy a natural hormone called glucagon-like peptide-1, which helps regulate appetite.
"Sustained high doses of GLP-1 levels far above than the body's typical production might result in the system to generate a reduced amount of its endogenous GLP-1, and could diminish sensitivity to its effects," explained Dr. Adam Collins, a dietetics researcher.
"Stopping of this GLP-1 'fix' results in appetite is no longer kept in check, making excessive eating a significant risk."
An Ongoing Issue?
Medical guidelines advise the injections for people with weight-linked health risks, accompanied by prescribed diet and exercise modifications.
A number of clinicians say that, due to the high risk of weight regain, the treatment is often long-term.
This perspective is supported by pharmaceutical companies, who say that the results "highlight the long-term character of obesity," similar to managing diseases like hypertension.
Patient Experiences
Users who have stopped the jabs explain a powerful return of hunger.
"It felt as if a switch flipping and you're instantly starving," recalled one woman.
This difficulty is worsened if patients have not adopted sustainable lifestyle or habit modifications during therapy.
Growing Adoption
Recent estimates suggest that a significant number of adults in the UK have used weight-loss jabs in the last 12 months, with desire remaining high.
- Adoption is more common among women than males.
- The middle-aged demographic shows the highest usage rates.
- Many obtain the drugs through private healthcare rather than public health services.
Ultimately, experts emphasize that while these medications are powerful agents for weight loss, they are not a magic fix and long-term success relies on integrated lifestyle support.
